Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 181   

Articles published

PFE 36.89 +0.22 (0.60%)
price chart
Analysts Update on Stocks: Pfizer, Inc. (NYSE:PFE) , Cerus Corporation (NASDAQ ...
Pfizer, Inc. (NYSE:PFE) diminished -0.49%, closing at $36.67 after floating between $36.50 and $36.91. The company has market capitalization of $222.40B.
How much the stock will be Cheap in next twelve months? Pfizer, Inc. (NYSE ...  Is stories
Earnings Estimates Analysis: Pfizer Inc. (NYSE:PFE)
The Company gained 0.05% and finished at $36.85. The daily volume was measured at 14.98 million shares. The 52-week high of the share price is $37.19 and the 52-week low is $28.25.
Pfizer Inc. (NYSE:PFE) Analysts Recommendations and Insider Trading
Pfizer Inc. (NYSE:PFE) stock is currently trading at about $36.71 and lots of rating firms seem to have a target price set on the stock.
Nike Inc (NYSE:NKE) & Pfizer Inc. (NYSE:PFE) Traders Recap  Money News (press release)
Analysts Rating Alert: Pfizer, Inc. (NYSE:PFE) , St. Jude Medical, Inc ...  Street Updates
Analysts Watching Stocks: Pfizer, Inc. (NYSE:PFE) , ACADIA Pharmaceuticals Inc ...
Pfizer, Inc. (NYSE:PFE) accumulated +0.14%, closing at $36.83 after floating between $36.65 and $36.87. The company has market capitalization of $223.37B.
WHO Backs Pfizer Inc. (NYSE:PFE) Prevnar 13, Prepares For International ...
Prevnar 13, the blockbuster vaccine of Pfizer Inc. (NYSE:PFE), has recently received the approval of the World Health Organization (WHO) with a new formulation of a four-dose vial.
Pfizer Inc. (PFE) Closes Flat on the Day for July 19
Pfizer Inc. currently has a total float of 6.06 billion shares and moves 23.77 million a day, on average. The stock opened at $36.67 on July 19 and traded between a low of $36.55 and a high of $36.87.
Johnson & Johnson versus Pfizer Inc Head to Head Compare
Pfizer Inc has a higher fundamental rating then Johnson & Johnson which has an impact on the head-to-head comparison. The CML Star Rating is an objective, quantifiable measure of a company's operating and financial condition.
Bankruptcy court approves $40 million takeover of Bind Therapeutics
A federal bankruptcy court Wednesday approved a $40 million takeover of cancer drug developer Bind Therapeutics Inc. by Big Pharma stalwart Pfizer Inc. The court order authorizing the sale closes the book on Bind, a 10-year-old Cambridge biotech ...
Pfizer Inc. (NYSE:PFE) Cleared to Buy Nanotech Drug Firm BIND Therapeutics ...  Benchmark Monitor
APNewsBreak: Arkansas execution drug made by Pfizer company
LITTLE ROCK, Ark. (AP) - An execution drug obtained by the Arkansas prison system this month appears to have been made by a subsidiary of Pfizer, even though the pharmaceutical giant has said it doesn't want its drugs to be used in executions. The ...
Pfizer cannot file legitimate complaint over execution drug, Legislator  eNCA
Stock under Radar: Pfizer Inc. (NYSE:PFE)
The Company gained 0.08% and finished at $36.74. The daily volume was measured at 13.48 million shares. The 52-week high of the share price is $37.19 and the 52-week low is $28.25.